Physician profile
Abraham Freilich
NPI 1730180795
$2,630.17
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $540 · 2021: $554 · 2022: $577 · 2023: $54.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $927.72 | 2019-2023 | Tremfya |
| Sun Pharmaceutical Industries INC. | $355.11 | 2019-2023 | Ilumya |
| Novartis Pharmaceuticals Corporation | $233.10 | 2019-2021 | |
| Abbvie INC. | $202.16 | 2019-2023 | |
| Pfizer INC. | $178.21 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $168.48 | 2019-2021 | |
| Genzyme Corporation | $160.75 | 2019-2021 | |
| Incyte Corporation | $77.28 | 2021-2022 | |
| Lilly USA, LLC | $72.58 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $70.33 | 2019 | |
| Biofrontera INC. | $37.55 | 2022 | |
| Galderma Laboratories, L.P. | $32.70 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.70 | 2019-2020 | |
| Celgene Corporation | $15.96 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $15.30 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.14 | 2020 | |
| Aclaris Therapeutics, INC. | $12.33 | 2019 | |
| Almirall LLC | $12.26 | 2019 | |
| Dermira, INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Freilich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.